Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging.
暂无分享,去创建一个
A. Lammertsma | R. Schuit | M. Yaqub | E. Smit | A. Poot | L. Schwarte | I. Bahce | S. Remmelzwaal | H. Hendrikse | E. A. van de Stadt | I. Bahce | Sharon Remmelzwaal